ClarityDX Prostate is a rapid test providing critical support to men and their physicians to make more informed decisions, with 3X the accuracy, about whether to biopsy after a high PSA test result. Order your test at https://t.co/PBw1zkTSMt
#prostatecancer#ClarityDXProstate
Coming up later this #LifeSciencesWeek: @nanostics will officially launch ClarityDX Prostate in Alberta- a new test that substantially improves the prediction of clinically significant prostate cancer.
Head now to https://t.co/dEn152n0WX to join this celebratory event!
Day 1 of #CUA2023! At booth 60 with #CUA president & Nanostics board member, Dr. Armen Aprikian. Come by! Don't miss the e-poster, moderated by Dr. Adam Kinnaird, June 25, 7:35 am, Session 9 at https://t.co/gCrMd4oC2a.
#diagnostics#prostatecancer#machinelearningalgorithms
Excited to share our new paper: Clinical analysis of EV-Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy. Published now in @CancerMedicineJ#diagnostics#ProstateCancer#MachineLearning
https://t.co/XKmfSGhFEm
Going to #CUA2023! Go to our booth #60 to chat about ClarityDX Prostate, a risk score to predict aggressive prostate cancer.
Dr. Kinnaird moderates the poster, go here to view and post questions: https://t.co/iXtwiTkPoJ #diagnostics#prostatecancer#machinelearningalgorithms
We welcome Todd McMullen as Nanostics’ Medical Laboratory Director. His expertise is invaluable as we launch ClarityDX Prostate, our prostate cancer test to improve patient care by accurately identifying men with high-risk cancer. https://t.co/Yzba9UbX8L
Looking forward to #ASCO23! Dr. Chris Wallis will present "Clinical analysis of a ML risk model to predict clinically significant prostate cancer and avoid unnecessary prostate biopsies". Please chat with Dr. Wallis! #diagnostics#prostatecancer#precisionhealth@WallisCJD
April 26, 2:10 pm MT, our CSO Desmond Pink is presenting "EVs and ML: novel diagnostic tools for bladder cancer detection" @ABInnovates 1st Health Gamechangers: Impact of Digital Tech in Research. See you there! @PinkDes#bladdercancer#diagnostics#uofa
The FIRST @ABInnovates Health Gamechangers Research Conference is SOLD OUT with over 180 registered!
Looking forward to seeing everyone there!
#Digitalhealth#Research
COO Catalina Vasquez is at the Canadian Women's Network pathway for Silicon Valley this week networking, learning, and building industry connections with investors, execs & founders in Silicon Valley. More info https://t.co/env7BtO4Ro #prostatecancer#diagnostics#networking
COO Catalina Vasquez and RFD Yukon chair @sean_secord joined @CBC Yukon Morning Elyn Jones today. Thanks to Yukon RFD funds the @UAlberta Lewis lab, @APCaRI & Nanostics developed a test to diagnose aggressive prostate cancer. https://t.co/hadQnqhvib @catavasher@RideForDad
ICYMI: Edmonton AM with Mark Connolly visited Nanostics - an Edmonton-based health company working on a diagnostic test for prostate cancer - and chatted with CCO Colin Coros! Listen at: https://t.co/2oYImH6ZMr
#diagnostics#prostatecancer@HIH_YEG@taprootyeg@EdmontonGlobal